Bionano Genomics (BNGO) announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesis was published with multiple studies highlighting the advantages of optical genome mapping, OGM, in chromoanagenesis research.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- Bionano Genomics announces CMS posted preliminary payment determination for OGM
- Bionano Genomics files to sell 2.03M share of common stock
- Bionano Genomics’ Earnings Call: Cautious Optimism Amid Challenges
- BioNano Genomics: Strategic Shift and Growth in Consumables Drive Buy Rating
- Eight option delistings on August 18th